| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.17M | 13.24M | 19.60M | 32.97M | 49.06M | 17.32M |
| Gross Profit | 1.31M | 5.38M | 9.82M | 15.83M | 18.66M | 15.82M |
| EBITDA | -182.00K | 1.53M | -7.52M | -32.02M | 27.56M | -2.33M |
| Net Income | 2.64M | 1.42M | -9.36M | -35.70M | 24.55M | -5.53M |
Balance Sheet | ||||||
| Total Assets | 52.19M | 77.02M | 110.75M | 201.77M | 288.62M | 301.24M |
| Cash, Cash Equivalents and Short-Term Investments | 4.64M | 22.22M | 19.77M | 5.51M | 28.14M | 9.42M |
| Total Debt | 0.00 | 0.00 | 8.29M | 64.88M | 102.31M | 129.24M |
| Total Liabilities | 2.77M | 4.52M | 12.98M | 73.30M | 111.42M | 143.41M |
| Stockholders Equity | 49.42M | 72.50M | 97.77M | 128.47M | 177.20M | 157.83M |
Cash Flow | ||||||
| Free Cash Flow | 3.44M | 6.88M | -443.00K | 13.07M | 26.14M | -14.68M |
| Operating Cash Flow | -701.00K | 7.05M | 1.10M | 14.45M | 32.68M | 6.54M |
| Investing Cash Flow | 17.74M | 30.46M | 90.67M | 14.03M | 18.04M | -14.84M |
| Financing Cash Flow | -33.69M | -35.06M | -77.52M | -51.12M | -32.00M | 3.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £62.47M | 4.85 | 10.22% | 8.23% | 8.48% | 207.85% | |
71 Outperform | £165.97M | 9.16 | 7.33% | 7.43% | -10.95% | -30.09% | |
67 Neutral | £239.66M | 5.97 | 9.81% | 6.64% | ― | ― | |
66 Neutral | £36.10M | 54.66 | 4.33% | 7.14% | -41.22% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
51 Neutral | £51.93M | -11.90 | -0.96% | 5.02% | -9.28% | ― | |
46 Neutral | £49.46M | -9.68 | -4.75% | 3.94% | 16.08% | 56.94% |